参考文献/References:
[1] 吴以刚. 妊娠相关血浆蛋白A 检测标准化研究进展[J]. 中国卫生产业,2016,13(18)：125-128. WU Yigang.Standardization research process ofpregnancy-associated plasma protein A test[J].ChinaHealth Industry,2016,13(18):125-128.
[2] 国家食品药品监督管理局.YY/T 1422-2016, 血清妊娠相关血浆蛋白A 检测试剂（盒）（定量标记免疫分析法）[S]. 北京：中国标准出版社，2017. National Medical Products Administration. YY/T 1422-2016,Pregnancy-associated plasma proteinA(PAPP-A)in serum test reagent(quantitative labellingimmunoassay)[S].Beijing:China Standard Press，2017.
[3] 中国合格评定国家认可委员会.CNAS-CL02，医学实验室质量和能力认可准则[S]. 北京：中国计量出版社.2014. China National Accreditation Service for ConformityAssessment. CNAS-CL02, Accreditation criteria for thequality and competence of medical laboratories（ISO15189：2012，IDT）[S]. Beijing:China MetologyPress, 2014.
[4] National Committee for Clinical Laboratory Standards.C28-A2,How to define and determine referenceintervals in the clinical laboratory.Approved guidelinesecondedition [S].Wayne: PA, NCCLS, C28-A2,2000.
[5] 王维鹏，邹琳，王治国. 新生儿疾病筛查与产前诊断实验室管理[M]. 北京：人民卫生教育出版社，2018:348. WANG Weipeng, ZOU Lin, WANG Zhiguo. Laboratorymanagement of neonatal disease screening and prenataldiagnosis[M]. Beijing: People’s Health EducationPress, 2018:348.
[6] 中华人民共和国卫生部.WS 322.1-2010，胎儿常见染色体异常与开放性神经管缺陷的产前筛查与诊断技术标准. 第1 部分: 中孕期母血清学产前筛查[S].北京：中国标准出版社，2010. Ministry of Health of the People’s Republic of China.WS 322.1-2010,Technical standards of prenatalscreening and diagnosis for fetal common chromosomalabnormalities and open neural tube defects.Part 1:Maternal serum prenatal screening in second trimester[S]. Beijing: China Standard Press，2010.
[7] 高刚, 林晓杰, 张力, 等. 孕早中期产前筛查血清标志物中位数的研究[J]. 国际遗传学杂志,2019,42(2)：120-123. GAO Gang, LIN Xiaojie, ZHANG Li,et al.Research onmedians of serum markers in prenatal screening duringthe first and second trimester of pregnancy[J]. Int JGenet, 2019,42(2):120-123.
[8] 蒋涛, 孙云, 张晓娟, 等. 南京地区孕早期产前筛查指标中位数建立和临床意义探讨[J]. 南京医科大学学报( 自然科学版),2011,31(1):71-75. JIANG Tao, SUN Yun, ZHANG Xiaojuan,et al.Establishmentof the median value of soft-marker infirst-trimester prenatal screening and investigationof it’s clinical significance of Nanjing area[J].ActaUniversitatis Medicinalis Nanjing(Natural Science),2011,31(1):71-75.
相似文献/References:
[1]王 碧,陈 霏.尿液KIM-1 及血浆PAPP-A 水平检测与妊娠期高血压疾病患者早期肾损伤的相关性研究[J].现代检验医学杂志,2020,35(04):79.[doi:10.3969/j.issn.1671-7414.2020.04.019]
WANG Bi,CHEN Fei.Correlation between the Levels of Urinary KIM-1 and Plasma PAPP-A and Early Renal Injury in Patients with Pregnancy Induced Hypertension[J].Journal of Modern Laboratory Medicine,2020,35(04):79.[doi:10.3969/j.issn.1671-7414.2020.04.019]
[2]李 欢a,焦峰军a,苏颜平b.冠心病患者血清VASP和PAPP-A的表达水平与冠状动脉病变程度的相关性研究[J].现代检验医学杂志,2022,37(03):114.[doi:10.3969/j.issn.1671-7414.2022.03.024]
LI Huana,JIAO Feng-juna,SU Yan-pingb.Study on the Correlation between the Expression Levels of Serum VASP and PAPP-A and the Severity of Coronary Artery Disease in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2022,37(04):114.[doi:10.3969/j.issn.1671-7414.2022.03.024]